Skip to main content
Orum Therapeutics, Inc. logo

Orum Therapeutics, Inc. — Investor Relations & Filings

Ticker · 475830 ISIN · KR7475830006 KO Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 475830

About Orum Therapeutics, Inc.

https://www.orumrx.com/

Orum Therapeutics is a clinical-stage biotechnology company that develops targeted protein degradation (TPD) therapeutics. The company's proprietary TPD²® platform creates a novel class of antibody-drug conjugates (ADCs), referred to as degrader-antibody conjugates (DACs). This technology combines the cell-targeting precision of antibodies with the catalytic action of protein degraders. The approach is designed to selectively deliver payloads to diseased cells to eliminate intracellular proteins that are difficult to target with conventional drugs. Orum's primary focus is on developing treatments for cancer, aiming to improve efficacy and safety over existing therapies.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 86% confidence The document is titled “분기보고서” (Quarterly Report) covering the period 2026-01-01 to 2026-03-31, includes detailed company overview, capital changes, share structure, business content, product pipelines, and substantive data. It is a comprehensive interim report, not merely an announcement. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
[기재정정]주식매수선택권행사
Share Issue/Capital Change Classification · 90% confidence The document is a regulatory disclosure detailing the exercise of employee stock options (“주식매수선택권 행사”), the number of new shares to be issued, the revised total share count, and the anticipated listing date for those new shares. This constitutes a change in the company’s capital structure via issuance of new shares. It is not an annual report, earnings release, board change, dividend notice, or any other category. The most specific match is Share Issue/Capital Change (Code: SHA).
2026-04-08 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 85% confidence The document is a corporate announcement detailing the exercise of employee and executive stock options, including issuance of new shares, exercise dates, share counts, and resulting changes in total issued share capital. This constitutes a share capital change via new share issuance upon option exercise, fitting the 'Share Issue/Capital Change' category (SHA).
2026-04-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 96% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Officer & Major Shareholder Specific Securities Ownership Report) and is filed with the Securities & Futures Commission and Korea Exchange. It details the director’s personal share transactions and holdings (dates, types, quantities, changes). This matches the definition of an insider share transaction report by company directors/executives (Director’s Dealing).
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a detailed "주식등의 대량보유상황보고서(일반)" (Report on Large Shareholdings) under Korea’s Capital Markets Act. It provides granular tables of shareholdings, shareholding ratios, related parties, changes in holdings, and reasons for changes. This corresponds to a Major Shareholding Notification rather than an annual or interim report, earnings release, or governance document. Therefore, it best fits the category “Major Shareholding Notification” (MRQ).
2026-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 85% confidence The document is a formal notification to the Financial Services Commission/Korea Exchange concerning the appointment, dismissal or mid-term retirement of outside directors (“사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고”). It lists details of new outside director appointments and changes in the board composition. This clearly falls under announcements of changes in the company’s board of directors, matching the Board/Management Information category.
2026-03-30 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.